Characterization of rabbit kidney and brain pancreatic polypeptide-binding neuropeptide Y receptors: Differences with Y1 and Y2 sites in sensitivity to amiloride derivatives affecting sodium transport

Regulatory Peptides

Volumn 82, Issue 1-3, 1999, Pages 91-102

  Parker, S L ^a   Parker, M S ^b   Crowley, W R ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Cation sensitivity; G protein agonist; Peptide receptor; Phospholipase C inhibitor; Sodium transport

Indexed keywords

AMILORIDE; AMILORIDE DERIVATIVE; PANCREAS POLYPEPTIDE; PHOSPHOLIPASE C INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CATION TRANSPORT; CONTROLLED STUDY; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RABBIT; SODIUM TRANSPORT;

AMILORIDE; AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; BRAIN; BRIDGED COMPOUNDS; CATIONS, MONOVALENT; ENZYME INHIBITORS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; HYPOTHALAMUS; IODINE RADIOISOTOPES; ION TRANSPORT; KIDNEY CORTEX; MALE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; PANCREATIC POLYPEPTIDE; PEPTIDE YY; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C; QUINACRINE; RABBITS; RATS; RECEPTORS, NEUROPEPTIDE; SEQUENCE ALIGNMENT; SODIUM; THIONES;

ORYCTOLAGUS CUNICULUS;

EID: 0032990871     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00049-X     Document Type: Article

References (44)

1. Larhammar D. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept. 62:1996;1-11.
2. Playford R.J., Mehta S., Upton P., Rentch R., Moss S., Calam J., Bloom S., Payne N., Ghatei M., Edwards R., Unwin R. Effect of peptide YY on human renal function. Am J Physiol. 268:1995;F754-F759.
3. Playford R.J., Cox H.M. Peptide YY and neuropeptide Y: two peptides intimately involved in electrolyte homeostasis. Trends Pharmacol Sci. 17:1996;436-438.
4. Bischoff A., Avramidis P., Erdbrugger W., Munter K., Michel M.C. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Br J Pharmacol. 120:1997;1335-1343.
5. 5 receptor. Eur J Pharmacol. 333:1997;R3-R5.
6. Larsen P.J., Kristensen P. The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex. Brain Res Mol Brain Res. 48:1997;1-6.
7. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnick M.A., Gadski R.A., Gehlert D.R., Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem. 270:1995;29123-29128.
8. Gehlert D.R., Schober D.A., Beavers L., Gadski R., Hoffman J.A., Smiley D.L., Chance R.E., Lundell I., Larhammar D. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol. 50:1996;112-118.
9. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
10. Hu Y., Bloomquist B.T., Cornfield L.J., DeCarr L.B., Flores-Riveros J.R., Friedman L., Jiang P., Lewis-Higgins L., Sadlowski Y., Schaefer J., Velazquez N., McCaleb M.L. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem. 271:1996;26315-26319.
11. Weinberg D.H., Sirinathsinghji D.J.S., Tan C.P., Shiao L., Morin N., Rigby M.R., Heavens R.H., Rapoport D.R., Bayne M.L., Cascieri M.A., Strader C.D., Linemeyer D.L., MacNeil D.J. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem. 271:1996;16435-16438.
12. Gregor P., Feng Y., DeCarr L.B., Cornfield L.J., McCaleb M.L. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J Biol Chem. 271:1996;27776-27781.
13. Larhammar D., Blomqvist A.G., Yee F., Jazin E., Yoo H., Wahlestedt C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem. 267:1992;10935-10938.
14. Parker S.L., Parker M.S., Crowley W.R. Characterization of Y1, Y2 and Y5 subtypes of neuropeptide Y (NPY) receptor in rabbit kidney. Regul Pept. 75/76:1998;127-143.
15. Walker P., Munoz M., Martinez R., Peitsch M.C. Acidic residues in extracellular loops of the human-Y1 neuropeptide Y receptor are essential for ligand binding. J Biol Chem. 269:1994;2863-2869.
16. Du P., Salon J.A., Tamm J.A., Cuifen H., Cui W., Walker M.W., Adham N., Dhanoa D.S., Islam I., Vaysse P.J., Dowling B., Shifman Y., Boyle N., Rueger H., Schmidlin T., Yamaguchi Y., Branchek T.A., Weinshank R., Gluchowski C. Modeling the G-protein coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Protein Eng. 10:1997;109-117.
17. Parker S.L., Parker M.S., Sweatman T., Crowley W.R. Characterization of G-protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain. Sensitivity to G-protein activators and inhibitors and to inhibitors of phospholipase C. J Pharmacol Exp Ther. 286:1998;1-12.
18. 2 subtype of neuropeptide Y receptor of rat brain. Eur J Pharmacol. 318:1996;193-200.
19. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding proteins. Anal Biochem. 107:1980;220-239.
20. Pearson W.R. Rapid and sensitive sequence comparisons with FASTP and FASTA. Methods Enzymol. 183:1990;63-98.
21. Fuhlendorff J., Johansen N.L., Melberg S.G., Thogersen H., Schwartz T.W. The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors. J Biol Chem. 265:1990;11706-11712.
22. 34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors. Eur J Pharmacol. 318:1996;485-490.
23. Oblatt-Montal M., Buehler L.K., Iwamoto T., Tomich J.M., Montal M. Synthetic peptides and four-helix bundle proteins as model systems for the pore-forming structure of channel proteins. I. Transmembrane segment M2 of the nicotinic cholinergic receptor channel is a key pore-lining structure. J Biol Chem. 268:1993;14601-14607.
24. Horstman D.A., Brandon S., Wilson A.L., Guyer C.A., Cragoe Jr E.J., Limbird L.E. An aspartate conserved among G-protein receptors confers allosteric regulation of α2-adrenergic receptors by sodium. J Biol Chem. 265:1990;21590-21595.
25. Quintana J., Wang H., Ascoli M. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors. Mol Endocrinol. 7:1993;767-775.
26. Matsumoto M., Nomura T., Momose K., Ikeda Y., Kondou Y., Akiho H., Togami J., Kimura Y., Okada M., Yamaguchi T. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem. 271:1996;27217-27220.
27. Howard M.J., Hughes R.J., Motulsky H.J., Mullen M.D., Insel P.A. Interactions of amiloride with α- and β-adrenergic receptors: amiloride reveals an allosteric site on α 2-adrenergic receptors. Mol Pharmacol. 32:1987;53-58.
28. Garritsen A., Ijzerman A.P., Beukers M.W., Cragoe E.J. Jr., Soudijn W. Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain. Biochem Pharmacol. 40:1990;827-834.
29. Hoare S.R., Strange P.G. Regulation of D2 dopamine receptors by amiloride and amiloride analogs. Mol Pharmacol. 50:1996;1295-1308.
30. Kleyman T.R., Cragoe E.J. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol. 105:1988;1-52.
31. Brown A.M., Birnbaumer L. Ionic channels and their regulation by G protein subunits. Annu Rev Physiol. 52:1990;197-213.
32. Yatani A., Birnbaumer L., Brown A.M. Direct coupling of the somatostatin receptor to potassium channels by a G protein. Metabolism. 39:1990;91-95.
33. Canessa C.M., Horisberger J.D., Schild L., Rossier B.C. Expression cloning of the epithelial sodium channel. Kidney Int. 48:1995;950-955.
34. Nielsen S., Agre P. The aquaporin family of water channels in kidney. Kidney Int. 48:1995;1057-1068.
35. Segel I.H. Biochemical Calculations. 1974;Wiley, New York.
36. Parker SL, Parker MS, Crowley WR. Correlations between sensitivity to alkylation and downregulation by neuropeptide Y (NPY) for NPY Y1 and Y2 subtype receptors of rat brain. Society of Neuroscience 1996 Annual Meeting, Washington DC 1996; Abstract No. 661.9.
37. Barbry P., Hofman P. Molecular biology of Na+ absorption. Am J Physiol. 273:1997;G571-G585.
38. Clackson T., Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science. 267:1995;383-386.
39. Daniels A.J., Matthews J.E., Viveros O.H., Leban J.J., Cory M., Heyer D. Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding. Mol Pharmacol. 48:1995;425-432.
40. Rist B., Ingenhoven N., Scapozza L., Schnorrenberg G., Gaida W., Wieland H.A., Beck-Sickinger A.G. The bioactive conformation of neuropeptide Y analogues at the human Y2- receptor. Eur J Biochem. 247:1997;1019-1028.
41. Ross E.M. Signal sorting and amplification through G protein-coupled receptors. Neuron. 3:1989;141-152.
42. Noel J., Roux D., Pouyssegur J. Differential localization of Na+/H+ exchanger isoforms (NHE1 and NHE3) in polarized epithelial cell lines. J Cell Sci. 109:1996;929-939.
43. + exchangers. Physiol Rev. 77:1997;51-74.
44. Wells T. Vesicular osmometers, vasopressin secretion and aquaporin-4: a new mechanism for osmoreception? Mol Cell Endocrinol. 136:1998;103-107.